STAAR Surgical ROA 2010-2023 | STAA
Current and historical return on assets (ROA) values for STAAR Surgical (STAA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| STAAR Surgical ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2023-12-31 |
$0.02B |
$0.49B |
4.83% |
| 2023-09-30 |
$0.02B |
$0.47B |
4.80% |
| 2023-06-30 |
$0.03B |
$0.44B |
6.21% |
| 2023-03-31 |
$0.03B |
$0.42B |
8.20% |
| 2022-12-31 |
$0.04B |
$0.42B |
10.38% |
| 2022-09-30 |
$0.04B |
$0.40B |
11.17% |
| 2022-06-30 |
$0.04B |
$0.38B |
10.59% |
| 2022-03-31 |
$0.03B |
$0.35B |
10.03% |
| 2021-12-31 |
$0.03B |
$0.35B |
9.10% |
| 2021-09-30 |
$0.02B |
$0.33B |
8.06% |
| 2021-06-30 |
$0.02B |
$0.29B |
7.98% |
| 2021-03-31 |
$0.01B |
$0.27B |
4.51% |
| 2020-12-31 |
$0.01B |
$0.26B |
2.62% |
| 2020-09-30 |
$0.01B |
$0.24B |
4.15% |
| 2020-06-30 |
$0.01B |
$0.22B |
3.39% |
| 2020-03-31 |
$0.01B |
$0.21B |
6.05% |
| 2019-12-31 |
$0.01B |
$0.21B |
6.81% |
| 2019-09-30 |
$0.01B |
$0.19B |
4.43% |
| 2019-06-30 |
$0.01B |
$0.19B |
4.04% |
| 2019-03-31 |
$0.01B |
$0.18B |
3.39% |
| 2018-12-31 |
$0.01B |
$0.17B |
4.07% |
| 2018-09-30 |
$0.00B |
$0.16B |
4.08% |
| 2018-06-30 |
$0.00B |
$0.08B |
5.30% |
| 2018-03-31 |
$0.00B |
$0.08B |
1.41% |
| 2017-12-31 |
$-0.00B |
$0.07B |
-2.96% |
| 2017-09-30 |
$-0.00B |
$0.07B |
-3.00% |
| 2017-06-30 |
$-0.01B |
$0.06B |
-7.69% |
| 2017-03-31 |
$-0.01B |
$0.07B |
-9.20% |
| 2016-12-31 |
$-0.01B |
$0.07B |
-18.60% |
| 2016-09-30 |
$-0.01B |
$0.07B |
-20.31% |
| 2016-06-30 |
$-0.01B |
$0.07B |
-20.63% |
| 2016-03-31 |
$-0.01B |
$0.06B |
-21.05% |
| 2015-12-31 |
$-0.01B |
$0.06B |
-11.57% |
| 2015-09-30 |
$-0.01B |
$0.06B |
-15.13% |
| 2015-06-30 |
$-0.01B |
$0.06B |
-16.74% |
| 2015-03-31 |
$-0.01B |
$0.06B |
-16.46% |
| 2014-12-31 |
$-0.01B |
$0.06B |
-14.40% |
| 2014-09-30 |
$-0.01B |
$0.06B |
-11.07% |
| 2014-06-30 |
$-0.00B |
$0.06B |
-4.80% |
| 2014-03-31 |
$-0.00B |
$0.06B |
-1.66% |
| 2013-12-31 |
$0.00B |
$0.06B |
0.00% |
| 2013-09-30 |
$0.00B |
$0.06B |
0.00% |
| 2013-06-30 |
$-0.00B |
$0.06B |
-1.86% |
| 2013-03-31 |
$-0.00B |
$0.05B |
-1.90% |
| 2012-12-31 |
$-0.00B |
$0.06B |
-1.95% |
| 2012-09-30 |
$0.00B |
$0.05B |
0.00% |
| 2012-06-30 |
$0.00B |
$0.05B |
0.00% |
| 2012-03-31 |
$0.00B |
$0.05B |
2.15% |
| 2011-12-31 |
$0.00B |
$0.05B |
2.25% |
| 2011-09-30 |
$0.00B |
$0.05B |
0.00% |
| 2011-06-30 |
$-0.00B |
$0.04B |
-2.45% |
| 2011-03-31 |
$-0.00B |
$0.04B |
-10.13% |
| 2010-12-31 |
$0.00B |
$0.04B |
0.00% |
| 2010-09-30 |
$0.00B |
$0.04B |
0.00% |
| 2010-06-30 |
$-0.00B |
$0.04B |
-1.90% |
| 2010-03-31 |
$0.00B |
$0.05B |
0.00% |
| 2009-12-31 |
$-0.01B |
$0.06B |
-10.57% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.304B |
$0.322B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
